Work

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)

Year: 2011

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-011-1670-4

Authors: I-SPY TRIAL Investigators, Cheryl Lin, Meredith Becker Buxton, Dan Moore, Helen Krontiras, Lisa Carey, Angela DeMichele, Leslie Montgomery, Debasish Tripathy, Constance Lehman, Minetta Liu, Olufunmilayo Olapade, Christina Yau, Donald Berry, Laura J. Esserman

Institutions: University of California, San Francisco, University of Alabama at Birmingham, UCSF Helen Diller Family Comprehensive Cancer Center, University of Alabama, Kirklin Clinic, University of North Carolina at Chapel Hill, University of Pennsylvania, Yeshiva University, University of Southern California, Albert Einstein College of Medicine, University of Washington, USC Norris Comprehensive Cancer Center, Seattle Cancer Care Alliance, Georgetown University, Georgetown University Medical Center, University of Chicago, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Global Cancer Incidence and Screening

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Breast Cancer Research Foundation, American College of Radiology Imaging Network, National Institutes of Health, National Cancer Institute

Awards: Biostatistics Data Management Center for ACRIN, G111615301, G1209692471, G2179140131, American College of Radiology Imaging Network, G2647518335, G2680506192, G2934786030, G3583859132, G3744195242, G4040562365, G4257885129, G5643875679, G6638695758, G7454439745, Cancer Center Support Grant

OpenAlex ID: W1986579304

FWCI: 2.342

Cites: 30

Cited by: 31

Related to: 10